News

28.04.2013

“Hopeful times” anticipated by leading MS advocate upon approval of MS treatment

The European Commission has granted marketing authorization for Aubagio 14 mg (teriflunomide), an oral therapy recommended for the treatment of…

The Written Declaration bid for neurodegenerative diseases: a useful experience

28.03.2013

The bid for a Written Declaration for neurodegenerative diseases (NDDs) in the workplace managed to gather 161 signatures from Members…

The Written Declaration bid for neurodegenerative diseases: a useful experience

28.03.2013

The bid for a Written Declaration for neurodegenerative diseases (NDDs) in the workplace managed to gather 161 signatures from Members…

28.02.2013

Lithuanian MS Union engaged in carrying an innovative and relevant project

Lithuanian MS Union is one of the partners engaged in carrying an innovative and relevant project in Lithuania The Heppy…

Lithuanian MS Union engaged in carrying an innovative and relevant project

28.02.2013

Lithuanian MS Union is one of the partners engaged in carrying an innovative and relevant project in Lithuania The Heppy…

Welcome from Maggie Alexander

02.11.2012

I’m delighted to be joining the European Multiple Sclerosis Platform (EMSP) at a key stage in the organisation’s development. From…

02.11.2012

Welcome from Maggie Alexander

I’m delighted to be joining the European Multiple Sclerosis Platform (EMSP) at a key stage in the organisation’s development. From…

1 53 54 55